Figure 2From: Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease Cost-effectiveness plane: incremental costs and incremental effects of enzyme replacement therapy relative to supportive therapy. Back to article page